Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The…
Antwerp, Belgium, May 27, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today…
Pratteln, Switzerland, May 26, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that its shareholders approved all motions by the…
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may…
May 15, 2026 20:23 ET | Source: Constellation Software Inc. TORONTO, May 15, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…
La Hulpe, Belgium – 15 May 2026, 7:00 CET – INSIDE INFORMATION – Banqup Group SA, (Euronext: BANQ) (Banqup, Company),…
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular…
April 30, 2026 18:45 ET | Source: TransAlta Corporation CALGARY, Alberta, April 30, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TSX:…
PASADENA, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, will…
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adoptedDividend of Euro 4.00 per share, with…